Although this decrease in ceramide levels in the skin is thought to be associated with the barrier dysfunction that causes AD, it has been suggested that the mast cell-dependent inflammation observed in AD could be accelerated as a result of the lack of ceramide-CD300f interaction [48]. The gene discussed is CD300LF; the disease is Alzheimer disease.